108 related articles for article (PubMed ID: 24519041)
1. [Molecular markers of gastrointestinal tumors and individualized treatment].
Wang H; Shou C
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):6-9. PubMed ID: 24519041
[TBL] [Abstract][Full Text] [Related]
2. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract][Full Text] [Related]
3. Select biomarkers for tumors of the gastrointestinal tract: present and future.
Bartley AN; Hamilton SR
Arch Pathol Lab Med; 2015 Apr; 139(4):457-68. PubMed ID: 25333834
[TBL] [Abstract][Full Text] [Related]
4. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies in gastrointestinal cancers.
Bronte G; Cicero G; Cusenza S; Galvano A; Musso E; Rizzo S; Sortino G; Roselli M; Bazan V; Fiorentino E; Russo A
Expert Opin Biol Ther; 2013 Jun; 13(6):889-900. PubMed ID: 23441760
[TBL] [Abstract][Full Text] [Related]
6. Proteomic approach toward personalized sarcoma treatment: lessons from prognostic biomarker discovery in gastrointestinal stromal tumor.
Kondo T; Suehara Y; Kikuta K; Kubota D; Tajima T; Mukaihara K; Ichikawa H; Kawai A
Proteomics Clin Appl; 2013 Jan; 7(1-2):70-8. PubMed ID: 23281253
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
8. Applications of EUS for the molecular characterization and treatment of gastrointestinal diseases--a review of the recent medical literature.
Bhutani MS
MedGenMed; 2005 May; 7(2):18. PubMed ID: 16369397
[No Abstract] [Full Text] [Related]
9. Gene therapy for gastrointestinal tract cancer: a review.
Heideman DA; Gerritsen WR; Craanen ME
Scand J Gastroenterol Suppl; 2000; (232):93-100. PubMed ID: 11232500
[TBL] [Abstract][Full Text] [Related]
10. Current status and problems in development of molecular target agents for gastrointestinal malignancy in Japan.
Boku N
Jpn J Clin Oncol; 2010 Mar; 40(3):183-7. PubMed ID: 20047861
[TBL] [Abstract][Full Text] [Related]
11. [New perspectives on medical treatment of gastric cancer].
Shen L; Lu ZH
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):103-8. PubMed ID: 22368010
[TBL] [Abstract][Full Text] [Related]
12. [Exploration of surgical impact on individualized and comprehensive treatment in gastrointestinal tumor].
Xu YX; Li R
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):796-8. PubMed ID: 20450615
[No Abstract] [Full Text] [Related]
13. Future diagnostic and therapeutic trends in endocrine cancers.
Spiegel AM; Libutti SK
Semin Oncol; 2010 Dec; 37(6):691-5. PubMed ID: 21167386
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumors (GIST).
Landi B; Bouche O; Blay JY
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S98-2S101. PubMed ID: 17151569
[No Abstract] [Full Text] [Related]
15. [Are the "4P" clinical strategies against gastrointestinal tumors still far away?].
Gao HJ; Guo Y
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):286-7. PubMed ID: 20627030
[No Abstract] [Full Text] [Related]
16. Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.
Aprile G; Giuliani F; Cordio S; Sartore-Bianchi A; Bencardino K; Ongaro E; Martines C; Giampieri R; Bordonaro R; Siena S; Cascinu S; Scartozzi M
Future Oncol; 2014 May; 10(7):1125-8. PubMed ID: 24947252
[TBL] [Abstract][Full Text] [Related]
17. [Metastatic brain tumors from gastrointestinal cancer: an analysis of patient background and treatment results].
Mizokami Y; Mitsuya K; Hayashi N; Yasui H; Harada H; Nishimura T; Nakasu Y
No Shinkei Geka; 2013 Aug; 41(8):669-77. PubMed ID: 23907473
[TBL] [Abstract][Full Text] [Related]
18. Novel ways to sensitise gastrointestinal cancer to apoptosis.
Schulze-Bergkamen H; Weinmann A; Moehler M; Siebler J; Galle PR
Gut; 2009 Jul; 58(7):1010-24. PubMed ID: 19520891
[TBL] [Abstract][Full Text] [Related]
19. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
[TBL] [Abstract][Full Text] [Related]
20. ERCC1: impact in multimodality treatment of upper gastrointestinal cancer.
Metzger R; Bollschweiler E; Hölscher AH; Warnecke-Eberz U
Future Oncol; 2010 Nov; 6(11):1735-49. PubMed ID: 21142660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]